About Belatacept
            
            Class: | Immunosuppressant, selective T-cell co-stimulation blocker  
Use: | Indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant  
Adult dose: | Initial dose: 10 mg/kg IV on day of transplantation, followed by 5 mg/kg IV on days 5, 14, and 28; then 5 mg/kg IV every 4 weeks thereafter  
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age  
Side effects: | Common side effects include anemia, leukopenia, thro
         
        
            
                
                
                    
                        Drug Class
                    
                    Immunosuppressant, selective T-cell co-stimulation blocker
                 
                
                
                    
                        Uses & Indications
                    
                    Indicated for the prophylaxis of organ rejection in adult patients receiving a kidney transplant
                 
                
                
                    
                        Storage Requirements
                    
                    Store powder for concentrate at 2°C to 8°C (36°F to 46°F); do not freeze; reconstituted solution should be used immediately or can be stored at 2°C to 8°C for up to 24 hours
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Bristol Myers Squibb GmbH & Co. KGaA, Germany
                    
                    
                    Package Size
                    1 Vial + 1 Syringe
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 3038.30
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose: 10 mg/kg IV on day of transplantation, followed by 5 mg/kg IV on days 5, 14, and 28; then 5 mg/kg IV every 4 weeks thereafter
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients under 18 years of age
                    
                 
                
                
                    
                        Side Effects
                    
                    Common side effects include anemia, leukopenia, thrombocytopenia, headache, nausea, diarrhea, and increased risk of infections
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Contraindicated in patients with a history of hypersensitivity to belatacept or any component of the formulation; also contraindicated in patients with active viral infections, such as Epstein-Barr virus (EBV)
         
        
        
            
                Important Warnings
            
            Increased risk of post-transplant lymphoproliferative disorder (PTLD) and other malignancies; monitor for signs of infection; caution in patients with a history of EBV infection; may cause serious allergic reactions; avoid use in patients with renal impairment
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.